Benchmark lowered the firm’s price target on Semler Scientific (SMLR) to $86 from $101 and keeps a Buy rating on the shares after Semler agreed to be acquired by Strive (ASST) in an all-stock deal. While the market is sorting out the longer-term implications of the transaction, it appears to the firm that Semler shares “represent an opportunity right now” and that this deal seems to have “rung the opening bell for consolidation in the corporate bitcoin (BTC-USD) treasury space,” the analyst tells investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMLR: